Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf57f5d6ba64a8540567bd58450793b6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D225-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 |
filingDate |
1987-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_277ec27159ddc20a2bb38e3c576a0124 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c40fbd366a3de891a00357934b9ff6a8 |
publicationDate |
1988-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-8802626-A1 |
titleOfInvention |
Penetration enhancers for transdermal delivery of systemic agents |
abstract |
Method for administering systemically active agents including therapeutic agents through the skin or mucosal membranes of humans and animals in a transdermal device or formulation comprising topically administering with said systemic agent an effective amount of a membrane penetration enhancer having structural formula (I), wherein X may represent sulfur or two hydrogen atoms; R' is H or a lower alkyl group having 1-4 carbon atoms; m is 2-6; n is 0-18 and R is -CH3, or a compound of formula (II) or (III), wherein R'' is H or halogen. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0374218-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0314008-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0374218-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0314008-A2 |
priorityDate |
1986-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |